Review article · 2026 · Open access
Bile acid signaling in health and disease
Molecular Biomedicine, 7(1), 193 · Published 2 October 2026 · DOI 10.1186/s43556-026-00603-4
In brief
“Bile acid signaling in health and disease” is a 2026 review article by Zhezhe Fan and 5 co-authors, published in Molecular Biomedicine. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Molecular Biomedicine.
- Citations
- 0
- References
- 322
- Authors
- 6
Abstract
Bile acids (BAs), cholesterol-derived amphipathic metabolites which are traditionally regarded as digestive surfactants, are now recognized as pleiotropic signaling molecules that act through ligand-, receptor-, and tissue-specific mechanisms to maintain systemic homeostasis. They exert biological functions via nuclear receptors (FXR, PXR, VDR, CAR) and membrane receptors (TGR5, S1PR2, MRGPRX4). These receptors activate transcriptional and membrane-initiated programs, including FXR–SHP/FGF19 feedback, TGR5–cAMP–PKA signaling, S1PR2–ERK/AKT/RhoA pathways, MRGPRX4-dependent Ca 2 ⁺ signaling, PXR/CAR/VDR-driven detoxification responses, and non-receptor-mediated membrane and mitochondrial stress pathways. This review discusses how the diversity of BA structures, hepatic synthesis, conjugation, transportation, enterohepatic circulation, and microbiota-mediated transformation generates receptor- and tissue-specific signals. Furthermore, we summarize the physiological functions of BA signaling in lipid, glucose, and energy metabolism, intestinal epithelial integrity, mucosal immunity, neuroendocrine regulation, musculoskeletal adaptation, and renal water-salt balance. Additionally, we discuss the effects of disrupted BA signaling on cholestatic and metabolic liver diseases, alcohol-associated liver disease, hepatocellular carcinoma, inflammatory bowel disease, BA diarrhea, colorectal cancer, obesity, type 2 diabetes, atherosclerosis, and biliary tract diseases. Finally, the therapeutic strategies that modulate BA signaling, including the use of FXR and TGR5 agonists, FGF19 analogues, transporter inhibitors, enzyme-targeting methods, microbiota-based treatments, and hydrophilic BA therapies, are evaluated. By categorizing BA biology according to the production of ligands, receptor activation, tissue responses, and disease mechanisms, this review highlights BA signaling as an integrated regulatory network and a tractable therapeutic axis in health and disease.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Fan, Z., He, M., Liang, T., 张必利, Zhao, N., & Li, P. (2026). Bile acid signaling in health and disease. Molecular Biomedicine, 7(1), 193. https://doi.org/10.1186/s43556-026-00603-4
MLA 9
Fan, Zhezhe, et al. “Bile acid signaling in health and disease.” Molecular Biomedicine, vol. 7, no. 1, 2026, p. 193. https://doi.org/10.1186/s43556-026-00603-4.
Chicago
Fan, Zhezhe, Mengyi He, Taiping Liang, 张必利, Na Zhao, and Pan Li. 2026. “Bile acid signaling in health and disease.” Molecular Biomedicine 7 (1): 193. https://doi.org/10.1186/s43556-026-00603-4.
Harvard
Fan, Z. et al. (2026) ‘Bile acid signaling in health and disease’, Molecular Biomedicine, 7(1), p. 193. doi:10.1186/s43556-026-00603-4.
IEEE
Z. Fan, M. He, T. Liang, 张必利, N. Zhao, and P. Li, “Bile acid signaling in health and disease,” Molecular Biomedicine, vol. 7, no. 1, p. 193, 2026, doi: 10.1186/s43556-026-00603-4.
BibTeX
@article{fan2026bile,
title = {{Bile acid signaling in health and disease}},
author = {Fan, Zhezhe and He, Mengyi and Liang, Taiping and 张必利 and Zhao, Na and Li, Pan},
journal = {Molecular Biomedicine},
year = {2026},
volume = {7},
number = {1},
pages = {193},
doi = {10.1186/s43556-026-00603-4},
url = {https://doi.org/10.1186/s43556-026-00603-4}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- bile acids
- bile acid signaling
- nuclear receptors
- farnesoid X receptor
- TGR5
- S1PR2
- enterohepatic circulation
- gut microbiota
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Fan, Z., He, M., Liang, T., 张必利, Zhao, N., & Li, P. (2026). Bile acid signaling in health and disease. Molecular Biomedicine, 7(1), 193. https://doi.org/10.1186/s43556-026-00603-4
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Molecular Biomedicine: sign in and open the PDF from this page.
Who wrote this paper?
Zhezhe Fan, Mengyi He, Taiping Liang, 张必利, Na Zhao, Pan Li.
What is the DOI of this paper?
10.1186/s43556-026-00603-4, permanently at https://doi.org/10.1186/s43556-026-00603-4. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.